SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-073501
Filing Date
2024-06-14
Accepted
2024-06-14 13:15:40
Documents
11
Period of Report
2024-06-12
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K bolt-20240612.htm   iXBRL 8-K 52334
  Complete submission text file 0000950170-24-073501.txt   170182

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT bolt-20240612.xsd EX-101.SCH 25968
14 EXTRACTED XBRL INSTANCE DOCUMENT bolt-20240612_htm.xml XML 4940
Mailing Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063
Business Address 900 CHESAPEAKE DRIVE REDWOOD CITY CA 94063 650-665-9295
Bolt Biotherapeutics, Inc. (Filer) CIK: 0001641281 (see all company filings)

IRS No.: 472804636 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39988 | Film No.: 241043986
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)